Dimitriadis GD, Lambadiari V. GLP-1 receptor agonists and SGLT-2 inhibitors as adjuncts to insulin in Type 1 diabetes: benefits and concerns. J Clin Endocrinol Metab 2022 Dec 12:dgac704. doi: 10.1210.
PMID: 36507904